Introduction to AI in Drug Discovery and Development

Overview of the drug discovery pipeline and its main stages.
The limitations of conventional drug development processes.
The role of Artificial Intelligence in transforming pharmaceutical R&D.
How AI improves efficiency, accuracy, and cost-effectiveness.
Key AI technologies: machine learning, deep learning, NLP, and data mining.
Industry case studies showing successful AI applications in drug design.

AI in Target Identification and Validation

The importance of understanding disease biology and identifying molecular targets.
Machine learning models for predicting gene-disease relationships.
AI-driven analysis of genomics, proteomics, and metabolomics datasets.
Integrative approaches combining biological networks and AI algorithms.
Examples of AI-based target identification in oncology, immunology, and neurology.

Machine Learning for Compound Screening and Lead Optimization

Principles of high-throughput and virtual screening using AI.
Predicting molecular binding affinity and drug-likeness using ML models.
Regression and classification methods for compound prioritization.
Applications of random forests, SVM, and neural networks in lead discovery.
How AI reduces time and cost in screening millions of compounds.

Deep Learning for Molecular Design and Prediction

Using neural networks to predict molecular properties and toxicity.
Deep generative models (GANs and autoencoders) for de novo molecule creation.
Reinforcement learning in optimizing chemical structures.
Integration of AI with cheminformatics software and lab automation systems.
Practical examples of AI-designed drug molecules progressing to trials.

AI in Predictive Toxicology and Safety Profiling

Importance of toxicity assessment in preclinical stages.
AI models for predicting drug metabolism and adverse reactions.
Toxicogenomic data analysis using deep learning.
Predictive analytics to reduce failure rates in late-stage trials.
Case studies on AI in predictive toxicology for safety assurance.

AI in Clinical Trial Optimization

The impact of AI on trial design, management, and patient recruitment.
Predictive models for identifying eligible participants.
Using AI for real-time monitoring and adaptive trial design.
Data mining from electronic health records and wearable devices.
Improving clinical data interpretation and reporting with AI.
Reducing trial duration through automation and predictive analytics.

Drug Repurposing and Personalized Therapeutics

Concept and benefits of AI-based drug repurposing.
Machine learning techniques for identifying new indications for existing drugs.
Integrating patient genomic and clinical data for personalized treatment.
Predicting therapeutic outcomes and optimizing drug dosage using AI.
Real-world examples of AI-enabled repurposing success in chronic diseases and COVID-19.

Data Management, Integration, and Quality in AI-Driven Research

Overview of pharmaceutical and biomedical data sources.
Data preprocessing, cleaning, and feature engineering for AI models.
Integration of heterogeneous datasets from laboratory and clinical systems.
Ensuring data integrity, reproducibility, and transparency.
Challenges in managing big data and ensuring interoperability.
Best practices for maintaining quality in AI-driven research.

AI and Regulatory Compliance in Drug Development

Overview of global regulations: FDA, EMA, and ICH guidelines for AI in pharmaceuticals.
Role of AI in documentation, reporting, and regulatory submission.
Ensuring explainability and accountability of AI algorithms.
Addressing ethical challenges such as bias and transparency.
Frameworks for validating and auditing AI models in the pharmaceutical industry.

Advanced Applications and Emerging Technologies

AI-driven automation in chemical synthesis and compound testing.
Quantum computing applications in molecular simulation.
Federated learning for multi-institutional research collaboration.
Integration of AI with robotics and smart laboratories.
Use of generative AI to accelerate hypothesis generation and experimental design.
Future outlook: the evolving relationship between AI, biotech, and nanotechnology.

The course integrates theoretical understanding with practical applications, enabling participants to acquire advanced skills in applying AI for pharmaceutical innovation. Learners will explore cutting-edge approaches in molecular design, predictive analytics, and data management that drive efficiency and precision in drug discovery. By mastering the intersection of computational science and biomedical research, participants will be able to support faster, safer, and more cost-effective therapeutic development within AI-enabled healthcare ecosystems.

AI-Driven Drug Discovery and Development Training Course in Geneva

Available Dates

Custom Date Selection

Available Cities

Objectives and Target Group

Course Content